Cargando…

Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients

40–70% of patients after a stroke, including a mild one, may experience cognitive impairment. Brain-derived neurotrophic factor (BDNF) plays a significant role in the pathogenesis and rehabilitation of ischemic stroke and also affects the patients' recovery prognosis. An association between cog...

Descripción completa

Detalles Bibliográficos
Autores principales: Havlovska, Yaroslava Yu., Lytvynenko, Nataliya V., Shkodina, Anastasiia D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033208/
https://www.ncbi.nlm.nih.gov/pubmed/36969561
http://dx.doi.org/10.1155/2023/5578850
_version_ 1784910960437231616
author Havlovska, Yaroslava Yu.
Lytvynenko, Nataliya V.
Shkodina, Anastasiia D.
author_facet Havlovska, Yaroslava Yu.
Lytvynenko, Nataliya V.
Shkodina, Anastasiia D.
author_sort Havlovska, Yaroslava Yu.
collection PubMed
description 40–70% of patients after a stroke, including a mild one, may experience cognitive impairment. Brain-derived neurotrophic factor (BDNF) plays a significant role in the pathogenesis and rehabilitation of ischemic stroke and also affects the patients' recovery prognosis. An association between cognitive impairment in the poststroke period and lower peripheral BDNF levels is known, but the prognostic significance of serum BDNF levels and clinical characteristics for the risk of developing cognitive impairment in the acute period remains uncertain. We conducted a prospective cohort study of patients in the acute phase of ischemic stroke. Clinical examination, assessment of neurological status, neuropsychological testing, and laboratory analyzes were performed on patients at 1 and 14 days after ischemic stroke. The state of cognitive functions was assessed by the Mini-Mental State Examination scale. Quantification of BDNF in blood serum was performed by solid-phaseenzyme-linked immunosorbent assay (ELISA). We found that within 14 days after an acute ischemic stroke, we found a decrease in the clinical severity of patients compared to 1 day of the onset of the disease before the start of treatment and a significant decrease in the level of BDNF in the blood serum of patients with ischemic stroke both on the first and on the 14th day. However, during the 2 weeks of the acute period, no significant changes were detected, despite the general improvement of the clinical condition. In our study, cognitive impairment was found in almost half of the patients on the first day of ischemic stroke, and there was no significant reduction in this prevalence over 2 weeks. We found that a low level of BDNF and a thrombotic subtype of ischemic stroke can be risk factors for cognitive impairment in the acute period, which can be useful in planning treatment and rehabilitation measures.
format Online
Article
Text
id pubmed-10033208
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-100332082023-03-23 Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients Havlovska, Yaroslava Yu. Lytvynenko, Nataliya V. Shkodina, Anastasiia D. Neurol Res Int Research Article 40–70% of patients after a stroke, including a mild one, may experience cognitive impairment. Brain-derived neurotrophic factor (BDNF) plays a significant role in the pathogenesis and rehabilitation of ischemic stroke and also affects the patients' recovery prognosis. An association between cognitive impairment in the poststroke period and lower peripheral BDNF levels is known, but the prognostic significance of serum BDNF levels and clinical characteristics for the risk of developing cognitive impairment in the acute period remains uncertain. We conducted a prospective cohort study of patients in the acute phase of ischemic stroke. Clinical examination, assessment of neurological status, neuropsychological testing, and laboratory analyzes were performed on patients at 1 and 14 days after ischemic stroke. The state of cognitive functions was assessed by the Mini-Mental State Examination scale. Quantification of BDNF in blood serum was performed by solid-phaseenzyme-linked immunosorbent assay (ELISA). We found that within 14 days after an acute ischemic stroke, we found a decrease in the clinical severity of patients compared to 1 day of the onset of the disease before the start of treatment and a significant decrease in the level of BDNF in the blood serum of patients with ischemic stroke both on the first and on the 14th day. However, during the 2 weeks of the acute period, no significant changes were detected, despite the general improvement of the clinical condition. In our study, cognitive impairment was found in almost half of the patients on the first day of ischemic stroke, and there was no significant reduction in this prevalence over 2 weeks. We found that a low level of BDNF and a thrombotic subtype of ischemic stroke can be risk factors for cognitive impairment in the acute period, which can be useful in planning treatment and rehabilitation measures. Hindawi 2023-03-15 /pmc/articles/PMC10033208/ /pubmed/36969561 http://dx.doi.org/10.1155/2023/5578850 Text en Copyright © 2023 Yaroslava Yu. Havlovska et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Havlovska, Yaroslava Yu.
Lytvynenko, Nataliya V.
Shkodina, Anastasiia D.
Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients
title Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients
title_full Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients
title_fullStr Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients
title_full_unstemmed Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients
title_short Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients
title_sort serum level of brain-derived neurotrophic factor and thrombotic type are predictive of cognitive impairment in the acute period of ischemic strokes patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033208/
https://www.ncbi.nlm.nih.gov/pubmed/36969561
http://dx.doi.org/10.1155/2023/5578850
work_keys_str_mv AT havlovskayaroslavayu serumlevelofbrainderivedneurotrophicfactorandthrombotictypearepredictiveofcognitiveimpairmentintheacuteperiodofischemicstrokespatients
AT lytvynenkonataliyav serumlevelofbrainderivedneurotrophicfactorandthrombotictypearepredictiveofcognitiveimpairmentintheacuteperiodofischemicstrokespatients
AT shkodinaanastasiiad serumlevelofbrainderivedneurotrophicfactorandthrombotictypearepredictiveofcognitiveimpairmentintheacuteperiodofischemicstrokespatients